As an increasing number of U.S. companies look toward the Indian market, a spate of U.S. law firms are shoring up their India-focused practices ahead of an expected wave of cross-border litigation and transactions.
Medical device maker Stryker Corp. faces a class action for selling a pain-relief device which allegedly caused permanent damage to injured patients.
Threatening to usher in a new wave of Vioxx lawsuits, a New Jersey appeals court has revived a proposed class action that seeks to force the pharmaceutical giant to cover medical-surveillance tests for individuals who took the controversial painkiller but have yet to suffer from any health problems.
In a blow to a group of Pennsylvania factory workers, a federal appeals court has granted Fenn Manufacturing Corp.’s motion for a new trial in a case involving a machine that allegedly causes permanent hand injuries.
The U.S. Food and Drug Administration revealed Thursday that it intends to ask Congress to authorize an $87.4 million increase to its prescription drug user fee program in order to upgrade its drug safety program and increase the development of new medications in the coming years.
Eli Lilly & Co. said Thursday that it will record charge of $495 million in the fourth quarter to settle product-liability claims related to the schizophrenia drug Zyprexa.
Toyota Motor Sales U.S.A. Inc. has settled a class action lawsuit brought on behalf of millions of people whose cars may have been damaged by engine oil sludge.
Medical device maker Medtronic Inc. may have to pay health insurers for the cost of replacing thousands of recalled pacemaker defibrillators, after a Minnesota judge set the stage for the consolidated complaint brought by insurers to continue to trail.
Merck & Co. Inc. and its lawyers have been chastised by a judge in the drug maker's dispute with the New England Journal of Medicine in the pending mass-tort litigation over the company’s former blockbuster drug Vioxx.
A class action brought by Louisiana residents against Murphy Oil USA Inc., whose oil tanker spilled into the neighborhood during Hurricane Katrina, is likely to be settled for $330 million, a federal judge indicated.
Eli Lilly & Co. has reached settlements in about 18,000 claims that the company didn’t properly disclose that patients taking Zyprexa, the company’s schizophrenia drug, were at risk to develop diabetes and other disorders, the company said Thursday.
Sony BMG has settled cases brought by prosecutors in California and Texas over the company’s failed anti-piracy technology intended to restrict the number of times a music CD could be copied.
The U.S. Food and Drug Administration and the drug makers are warning the public that two patients who have taken non-Hodgkins lymphoma and rheumatoid arthritis drug Rituxan have died from a rare nervous system disease.
Eli Lilly & Co. downplayed the risks of its schizophrenia and bipolar disorder drug Zyprexa while also encouraging doctors to prescribe the drug for patients that had neither condition, according to company marketing documents.
Merck & Co. Inc. has notched another win in a personal injury suit stemming form the use of the painkiller Vioxx, a development the company is touting as a vindication of its strategy to tackle thousands of Vioxx product liability claims individually. But an attorney for the plaintiff says it’s too early for Merck to be crowing.
A New Orleans jury in the twelfth civil trial over Merck & Co.’s ill-fated Vioxx headed into deliberations on Wednesday after lawyers representing the pharmaceutical giant called into question the credibility of a Tennessee man who had a heart attack in 2003 after taking the painkiller.
The legal woes keep piling up for Ortho-McNeil Pharmaceutical Co. The manufacturer of the popular birth-control patch was back in court Tuesday to face a wrongful death lawsuit brought by a 26-year-old woman and a mass action brought on behalf of 55 women who claim the contraceptive caused blood clots and other serious illnesses.
A Florida man has sued Johnson & Johnson for failing to alert him to the potential dangers of drug-coated stents, which are used to treat heart disease in angioplasties.
A U.S. appeals court’s decision this week to unbundle class actions in litigation against top investment banks could have consequences for wide swaths of the law, lawyers agree.
Just a month after GlaxoSmithKline PLC agreed to pay $63.8 million to settle claims in a class action lawsuit over its antidepressant drug Paxil, the U.K. drug maker is facing another slew of lawsuits over birth defects allegedly caused by the drug.